Add to your lists

Recommended Content

Picture of All-In Podcast
All-In Podcast

LA's Wildfire Disaster, Zuck Flips on Free Speech, Why Trump Wants Greenland

Jan. 11, 2025, 2:08 a.m.

No Paywall
Picture of Tech Investment Ideas
Tech Investment Ideas
Website logo

ASML's Strategy to Extend Moore's Law

Jan. 7, 2025, 9:50 a.m.

No Paywall
Picture of Platformer
Platformer
Website logo

OpenAI says it knows how to make superintelligence now

Jan. 7, 2025, 1:32 a.m.

Some Paywall
Picture of Tanay’s Newsletter
Tanay’s Newsletter
Website logo

Comparing the Financials of Databricks and Snowflake

Dec. 30, 2024, 11:35 p.m.

No Paywall
Picture of The Entertainment Strategy Guy
The Entertainment Strategy Guy
Website logo

The Future of TV or Just Another Netflix Hit?

Dec. 19, 2024, 12:10 a.m.

No Paywall
FinBrowser logo
Login Sign Up

How would you rate this source in terms of content quality?
Source Picture

Endpoints News

Picture of Endpoints News

Tags

Online Publication

Similiar Sources

Picture of BioPharma Dive
BioPharma Dive
Biotech - News 8.0
Picture of Biopharma Reporter
Biopharma Reporter
Biotech - News 8.0
Picture of Cafepharma
Cafepharma
Biotech - News 8.0
Picture of Drug Delivery Business
Drug Delivery Business
Biotech - News 8.0
Picture of Drugs.com
Drugs.com
Biotech - News 8.0
Picture of Evaluate
Evaluate
Biotech - News 8.0
Picture of Fierce Biotech
Fierce Biotech
Biotech - News 8.0
Picture of GEN
GEN
Biotech - News 8.0
Picture of Labiotech
Labiotech
Biotech - News 8.0
Picture of Pharmafile
Pharmafile
Biotech - News 8.0

Summary

Sector Biotech
Content Type News
Website Other
Paywall Semi

Ratings

Average Rating 8.0
Ratings 1
Your Rating Rate
Ranking 707

Content

Picture of Endpoints News
Endpoints News
Website logo

AstraZeneca exec stresses Calquence's patent life ahead of next Medicare negotiations

Jan. 22, 2025, 8:39 p.m.

Some Paywall
Picture of Endpoints News
Endpoints News
Website logo

Vanda loses constitutional fight over FDA's drug talks with competitors

Jan. 22, 2025, 8:31 p.m.

Some Paywall
Picture of Endpoints News
Endpoints News
Website logo

J&J reinforces Caplyta blockbuster projections, won't shelve neuro prospects

Jan. 22, 2025, 8:14 p.m.

Some Paywall
Picture of Endpoints News
Endpoints News
Website logo

Chinese startup begins first clinical trial using CRISPR to edit cells directly in the bone marrow

Jan. 22, 2025, 8:02 p.m.

Some Paywall
Picture of Endpoints News
Endpoints News
Website logo

Samsung Biologics hits revenue high, secures largest contract to date

Jan. 22, 2025, 7:19 p.m.

Some Paywall
Picture of Endpoints News
Endpoints News
Website logo

Health navigation company Quantum Health lays off 4% of workforce

Jan. 22, 2025, 5:55 p.m.

Some Paywall
Picture of Endpoints News
Endpoints News
Website logo

Updated: Biogen enacts layoffs across its research unit

Jan. 22, 2025, 4:58 p.m.

Some Paywall
Picture of Endpoints News
Endpoints News
Website logo

RFK Jr. says he’ll divest interests in CRISPR Therapeutics if confirmed for HHS chief

Jan. 22, 2025, 4:50 p.m.

Some Paywall
Picture of Endpoints News
Endpoints News
Website logo

Xilio reports handful of responses for combo in colorectal cancer

Jan. 22, 2025, 4:20 p.m.

Some Paywall
Picture of Endpoints News
Endpoints News
Website logo

Shanghai Bao, Sichuan Biokin file IPOs in Hong Kong; Disc's $200M offering

Jan. 22, 2025, 3:33 p.m.

Some Paywall
Picture of Endpoints News
Endpoints News
Website logo

Tris Pharma declares Phase 3 win for 'opioid-like' painkiller. Can it sell?

Jan. 22, 2025, 1:30 p.m.

Some Paywall
Picture of Endpoints News
Endpoints News
Website logo

J&J’s Spravato hit $1B in revenue in 2024

Jan. 22, 2025, 12:30 p.m.

Some Paywall
Picture of Endpoints News
Endpoints News
Website logo

Inhibrx’s early colorectal cancer data clouded by patient death

Jan. 22, 2025, 12:18 p.m.

Some Paywall
Picture of Endpoints News
Endpoints News
Website logo

Regeneron CSO George Yancopoulos on AI's hype and potential

Jan. 22, 2025, noon

Some Paywall
Picture of Endpoints News
Endpoints News
Website logo

GLP-1s can cut the risk of Alzheimer’s. What does that mean for Novo Nordisk?

Jan. 22, 2025, 11:56 a.m.

Some Paywall
Picture of Endpoints News
Endpoints News
Website logo

Oncology biotech ArriVent does another China ADC deal, this time with Lepu Biopharma

Jan. 22, 2025, 10:48 a.m.

Some Paywall
Picture of Endpoints News
Endpoints News
Website logo

US withdrawal from WHO could jeopardize information sharing

Jan. 21, 2025, 9:35 p.m.

Some Paywall
Picture of Endpoints News
Endpoints News
Website logo

Renewed mifepristone fight will test Trump’s abortion stance

Jan. 21, 2025, 9:32 p.m.

Some Paywall
Picture of Endpoints News
Endpoints News
Website logo

J&J's Spravato wins expanded label for depression as singular treatment

Jan. 21, 2025, 5:58 p.m.

Some Paywall
Picture of Endpoints News
Endpoints News
Website logo

Sanofi says no supply interruptions after landing FDA warning letter for US site

Jan. 21, 2025, 5:41 p.m.

Some Paywall
Picture of Endpoints News
Endpoints News
Website logo

What to make of UnitedHealth Group’s rebate move

Jan. 21, 2025, 3:59 p.m.

Some Paywall
Picture of Endpoints News
Endpoints News
Website logo

China's drug development explosion forces a US biotech reckoning

Jan. 21, 2025, 3:30 p.m.

Some Paywall
Picture of Endpoints News
Endpoints News
Website logo

FDA puts Atara’s INDs on hold after rejection; Ascletis' safety data for obesity pill

Jan. 21, 2025, 3:22 p.m.

Some Paywall
Picture of Endpoints News
Endpoints News
Website logo

Ascentage estimates $133M in proceeds as it plans dual listing

Jan. 21, 2025, 3:11 p.m.

Some Paywall
Picture of Endpoints News
Endpoints News
Website logo

With support from NFL owner Jeffrey Lurie, Icelandic biotech closes Series A for oral Alzheimer's drug

Jan. 21, 2025, 3 p.m.

Some Paywall